We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Guidance Lays Out Guidance for Sponsors to Increase Diversity in Trials
FDA Guidance Lays Out Guidance for Sponsors to Increase Diversity in Trials
As part of its ongoing efforts to make clinical trials more representative of the population, the FDA yesterday issued a final guidance on what sponsors should do to make trials more accessible and appealing to under-represented racial, ethnic, gender and age groups.